Edition:
India

Vectura Group PLC (VEC.L)

VEC.L on London Stock Exchange

84.65GBp
19 Sep 2019
Change (% chg)

1.85 (+2.23%)
Prev Close
82.80
Open
82.55
Day's High
85.35
Day's Low
82.55
Volume
1,571,378
Avg. Vol
586,917
52-wk High
90.15
52-wk Low
65.85

Select another date:

Mon, Jun 10 2019

UPDATE 1-Drugmaker Vectura parts ways with CEO Ward-Lilley

June 10 British drugmaker Vectura Group Plc's chief executive officer James Ward-Lilley will step down at the end of this month, the company said on Monday, saying it had agreed with the industry veteran that a change of leadership was needed.

Drugmaker Vectura CEO James Ward-Lilley to step down

June 10 British drugmaker Vectura Group Plc's chief executive officer, James Ward-Lilley, will step down by the end of this month, the company said on Monday.

UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S

British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and has been awarded $89.7 million in damages for the period from August 2016 through December 2018.

UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S

British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and has been awarded $89.7 million in damages for the period from August 2016 through December 2018.

UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S.

May 4 British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and has been awarded $89.7 million in damages for the period from August 2016 through December 2018.

Select another date: